Samsung betting big on smartphones

Smartphones account for about 10 per cent of the handsets sold by the company in India

PTI | June 15, 2011



South Korean mobile handset maker Samsung is betting big on smartphones and expects the segment to contribute 15 per cent to the sales volume by the year-end.

Currently, smartphones account for about 10 per cent of the handsets sold by the company in the country.

"Over 1,300 Galaxy SII handsets were booked online in 10 days. We have received good response from the market on this device and we expect this model to give 20 per cent volume growth in smartphone sales month-over-month," a company spokesperson said.

She declined to comment on revenue details since the company does not divulge revenue by products.

Priced at Rs 32,890, Galaxy SII was available for online booking from May 26 and in open market from June 9. Samsung has 15 devices in its smartphone portfolio in the country.

The company is also eyeing 40 per cent share of the Indian smartphone market by December this year.

According to industry estimates, current smartphone sales are about five million a year, and it is expected to grow to about eight million units in annual sales next year.

Growing smartphones sales are expected to get a further filip with the roll out of 3G services in the country. 3G services, which offer high-speed Internet access, have already been doled out by operators like Bharti airtel, Vodafone, Idea Cellular and Aircel.

India is the world's second-largest market, after China, for telecom services with 826.93 million subscribers at the end of April 2011.

US-based Apple has also launched its iPhone 4 in India and rivals Nokia, LG and Motorola are also introducing newer smartphones to compete in the heated smartphone race.




 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter